Suppr超能文献

[肺自体移植技术治疗Ⅲ期中央型肺癌]

[Lung auto-transplantation technique in the treatment for stage III central lung cancer].

作者信息

Jiang Feng, Xu Lin, Yuan Fang-liang, Huang Jian-feng, Lu Xin-xin, Zhang Xiao-ying

机构信息

Department of Thoracic Surgery, Jiangsu Cancer Hospital, Nanjing 210009, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2010 May 18;90(19):1329-32.

Abstract

OBJECTIVE

To assess the feasibility and benefit of lung auto-transplantation technique in surgical treatment for stage III central lung cancer.

METHODS

From Aug 2000 to June 2007 eight patients, who were proved to be malignant pathologically through fiber-bronchoscope before operations and could not tolerate pneumonectomy, underwent lung auto-transplantations. The "cutdown" lower lobe was flushed with heparin solution at 20 degrees C. Since the length of resected bronchus or pulmonary artery involved by tumor was too long to perform tension-free anastomosis, we transplanted the inferior pulmonary vein to the proximal stump of the superior pulmonary vein. The bronchus and pulmonary artery were anastomosed in turn. Then radical hilar and mediastinal lymphadenectomy was performed.

RESULTS

No anastomotic stoma fistula occurred in these 8 patients. Until Jan 2008, six of the eight patients who underwent lung autotransplantations, had been free of tumor recurrence for 7-90 months with good quality of life. And the median time was 33 months. Radioisotope scanning of the replanted lobes of three patients revealed normal perfusion 18, 24 and 72 months postoperatively. One patient received resection of the replanted lobe because of pulmonary vein thrombus on the 2nd day after transplantation, and died of respiratory failure caused by pulmonary relapse on 15th month postoperatively. Another patient died of brain metastases 31 months postoperatively.

CONCLUSION

Lung auto-transplantation is an alternative technique for pulmonary preservation for patient with stage III centrally placed lung cancer, whose cardio-pulmonary functions is too poor to undergo pneumonectomy.

摘要

目的

评估肺自体移植技术在Ⅲ期中央型肺癌外科治疗中的可行性及益处。

方法

2000年8月至2007年6月,8例患者术前经纤维支气管镜病理证实为恶性且无法耐受肺切除术,接受了肺自体移植。“切取”的下叶在20℃用肝素溶液冲洗。由于肿瘤累及的切除支气管或肺动脉长度过长,无法进行无张力吻合,我们将下肺静脉移植到上肺静脉近端残端。依次吻合支气管和肺动脉。然后进行根治性肺门及纵隔淋巴结清扫术。

结果

这8例患者均未发生吻合口瘘。至2008年1月,8例接受肺自体移植的患者中有6例无肿瘤复发7至90个月,生活质量良好。中位时间为33个月。3例患者移植肺叶的放射性核素扫描显示术后18、24和72个月灌注正常。1例患者因移植后第2天肺静脉血栓形成接受移植肺叶切除,术后15个月死于肺复发引起的呼吸衰竭。另1例患者术后31个月死于脑转移。

结论

肺自体移植是心肺功能太差无法耐受肺切除术的Ⅲ期中央型肺癌患者肺保留的一种替代技术。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验